다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lexicon Pharmaceuticals Inc (LXRX)
Lexicon Pharmaceuticals Inc (LXRX) 뉴스

LXRX

Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LXRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/03	05:05	GlobeNewswire Inc.	Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/04/29	22:00	GlobeNewswire Inc.	Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/04/29	20:00	GlobeNewswire Inc.	Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/04/18	21:00	GlobeNewswire Inc.	Lexicon Pharmaceuticals to Host 2024 Investor Day	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/04/03	21:00	GlobeNewswire Inc.	Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/25	22:20	GlobeNewswire Inc.	Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/12	21:00	GlobeNewswire Inc.	New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/12	05:25	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/11	20:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/11	20:15	GlobeNewswire Inc.	Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/11	20:05	GlobeNewswire Inc.	Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/11	20:00	GlobeNewswire Inc.	Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/01	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/03/01	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/02/13	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2024/01/08	21:00	GlobeNewswire Inc.	Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/12/30	07:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/12/30	07:27	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/12/30	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/12/22	06:15	GlobeNewswire Inc.	Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/11/30	21:30	GlobeNewswire Inc.	Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc
2023/11/22	21:30	GlobeNewswire Inc.	Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference	NASDAQ:LXRX	Lexicon Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:LXRX

1 2 3 4 5 6 7 8 9 10 다음 >>

Bank of America

JP Morgan Chase

Health Care Select Sector

Financial Select Sector

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관